ZTS Q1 2020 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+5.4% YoY

Gross Profit

$1.0B67.5% margin

Operating Income

$539M35.1% margin

Net Income

$423M27.6% margin

EPS (Diluted)

$0.88

QoQ Revenue Growth

-8.4%

Cash Flow

Operating Cash Flow

$408M

Free Cash Flow

$314M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$11.5B

Total Liabilities

$8.8B

Stockholders' Equity

$2.8B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.5B	+5.4%
Gross Profit	$1.0B	$899M	+15.1%
Operating Income	$539M	$428M	+25.9%
Net Income	$423M	$312M	+35.6%

Revenue Segments

Dogs and Cats

$746M50%

Cattle

$370M25%

Swine

$157M10%

Poultry

$148M10%

Horses

$51M3%

Fish

$26M2%

Geographic Segments

United States Segment

$786M52%

International Segment

$728M48%